A 59-year-old man with bloody stool was diagnosed as having sigmoid colon cancer and metastatic anal fistula cancer through a biopsy via colonoscopy at a nearby hospital. He was introduced to our department for treatment. Enhanced computed tomography (CT) and enhanced magnetic resonance imaging (MRI) revealed three metastatic tumors in the liver (S2, S4, and S5). The preoperative diagnosis was sigmoid colon cancer, T4a (SE), N0, H1, P0, M (metastasis of the anal fistula and liver), Stage IV. We initiated neoadjuvant chemotherapy with S-1, oxaliplatin (SOX), and bevacizumab. After 6 courses of the treatment, colonoscopy, CT, and MRI revealed that all the lesions had reduced in size. We performed a laparoscopic abdominoperineal resection. One month later, we performed a liver resection of the liver metastasis. Final pathological examination revealed complete regression of the metastases of the anal fistula and liver. His postoperative course was uneventful without tumor relapse. SOX plus bevacizumab as neoadjuvant chemotherapy for colon cancer with metastases to the anal fistula and liver can help attain drastic tumor regression before surgical intervention. Key words：sigmoid colon cancer，metastatic anal fistula cancer，neoadjuvant chemotherapy
